| Date Filed | Type | Description |
| 06/07/2023 |
4
| JOHNSON JOHN (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 42,500 shares
@ $0 |
|
| 06/05/2023 |
4
| JOHNSON JOHN (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 6,459 restricted stock units
@ $0 |
|
| 05/16/2023 |
4
| JOHNSON JOHN (Director) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 62,500 options to buy
@ $0.42, valued at
$26.3k
|
|
| 12/20/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/08/2021 |
4/A
| JOHNSON JOHN (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 478,312 shares
@ $0
Granted 10,367 options to buy
@ $22.39, valued at
$232.1k
Granted 31,360 options to buy
@ $7.02, valued at
$220.1k
Granted 31,360 options to buy
@ $5.62, valued at
$176.2k
Granted 31,360 options to buy
@ $9.89, valued at
$310.2k
Granted 215,600 options to buy
@ $1.99, valued at
$429k
Granted 68,600 options to buy
@ $2.43, valued at
$166.7k
Granted 19,650 options to buy
@ $2.37, valued at
$46.6k
|
|
| 10/06/2021 |
4
| JOHNSON JOHN (CEO) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Disposed/sold 610,092 shares
@ $0
Disposed/sold 495,724 options to buy
@ $0 |
|
| 10/05/2021 |
4
| JOHNSON JOHN (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 478,312 shares
@ $0
Granted 10,367 options to buy
@ $22.39, valued at
$232.1k
Granted 31,360 options to buy
@ $7.02, valued at
$220.1k
Granted 31,360 options to buy
@ $5.62, valued at
$176.2k
Granted 31,360 options to buy
@ $9.89, valued at
$310.2k
Granted 215,600 options to buy
@ $1.99, valued at
$429k
Granted 68,600 options to buy
@ $2.43, valued at
$166.7k
|
|
| 10/05/2021 |
4
| JOHNSON JOHN (CEO) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Paid exercise price by delivering 334,868 shares
@ $2.06, valued at
$689.8k
|
|
| 10/05/2021 |
3
| JOHNSON JOHN (Director) has filed a Form 3 on Xeris Biopharma Holdings, Inc. |
| 07/21/2021 |
4
| JOHNSON JOHN (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Granted 27,638 options to buy
@ $19.44, valued at
$537.3k
|
|
| 07/21/2021 |
3
| JOHNSON JOHN (Director) has filed a Form 3 on Axogen, Inc. |
| 07/07/2021 |
4
| JOHNSON JOHN (CEO) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Paid exercise price by delivering 50,867 shares
@ $3.08, valued at
$156.7k
|
|
| 06/30/2021 |
4
| JOHNSON JOHN (Director) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 25,000 options to buy
@ $4.16, valued at
$104k
|
|
| 04/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| JOHNSON JOHN (CEO) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Granted 491,000 shares
@ $0 |
|
| 07/07/2020 |
4
| JOHNSON JOHN (CEO) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Granted 315,000 shares
@ $0 |
|
| 07/02/2020 |
4
| JOHNSON JOHN (Director) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 13,194 shares
@ $18, valued at
$237.5k
Disposed/sold 7,281 restricted stock units
@ $18, valued at
$131.1k
Disposed/sold 11,377 options to buy
@ $17.94, valued at
$204.1k
Disposed/sold 54,991 options to buy
@ $0 |
|
| 06/18/2020 |
4
| JOHNSON JOHN (Director) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 27,602 options to buy
@ $1.77, valued at
$48.9k
|
|
| 06/15/2020 |
4
| JOHNSON JOHN (Director) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Granted 7,281 shares
@ $0
Granted 11,377 options to buy
@ $17.94, valued at
$204.1k
|
|
| 05/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2020 |
4
| JOHNSON JOHN (Director) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.81, valued at
$45.3k
|
|
| 04/29/2020 |
3
| JOHNSON JOHN (Director) has filed a Form 3 on Verastem, Inc. |
| 04/10/2020 |
4
| JOHNSON JOHN (Executive Chairman) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Granted 182,500 shares
@ $0
Granted 87,500 options to buy
@ $1.9, valued at
$166.3k
|
|
| 11/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2019 |
4
| JOHNSON JOHN (CEO) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Sold 13,000 shares
@ $5.5724, valued at
$72.4k
|
|
| 06/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2019 |
4
| JOHNSON JOHN (Director) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Granted 4,194 shares
@ $0
Granted 6,991 options to buy
@ $26.09, valued at
$182.4k
|
|
| 05/16/2019 |
4
| JOHNSON JOHN (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Granted 40,000 shares
@ $0 |
|
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/29/2018 |
4
| JOHNSON JOHN (Interim CEO) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 150,000 options to buy
@ $2.8, valued at
$420k
Granted 50,000 restricted stock units
@ $0 |
|
| 06/19/2018 |
4
| JOHNSON JOHN (Director) has filed a Form 4 on HISTOGENICS CORP|
Txns:
| Granted 25,000 options to buy
@ $2.97, valued at
$74.3k
|
|
|